Skip to main content
SCYNEXIS INC logo

SCYNEXIS INC — Investor Relations & Filings

Ticker · SCYX ISIN · US8112922005 LEI · 529900XBHFGMNTU70154 US Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2015-04-22 Remuneration Information
Country US United States of America
Listing US SCYX

About SCYNEXIS INC

https://www.scynexis.com/

SCYNEXIS, Inc. is a biotechnology company focused on the discovery and development of novel anti-infectives to overcome difficult-to-treat and drug-resistant fungal infections. The company is pioneering a new class of broad-spectrum antifungal agents called 'fungerps,' which are triterpenoid-based compounds. These agents are being developed in both oral and intravenous formulations to treat a range of serious, invasive, and life-threatening fungal diseases, particularly those encountered in hospital environments. SCYNEXIS aims to address the significant global health threat of antifungal resistance by providing innovative therapeutic options where existing treatments are limited or ineffective. The company's development pipeline includes second-generation fungerp candidates.

Recent filings

Filing Released Lang Actions
DEFINITIVE ADDITIONAL MATERIALS
Remuneration Information Classification · 95% confidence The document is titled 'DEFA14A' which corresponds to 'Definitive Additional Materials' related to a proxy statement. It is a Schedule 14A filing with the SEC, which is used for proxy solicitation materials. The content includes details about the Annual Meeting of Stockholders, voting instructions, board nominees, and proposals to be voted on. It is not the proxy statement itself but additional materials related to it. This type of filing is classified under 'Remuneration Information' or proxy solicitation materials, but since it is definitive additional materials to a proxy statement, the best fitting category is 'DEF 14A' which covers reports detailing compensation and proxy materials for directors and executives. The document is not an annual report, earnings release, or other financial report, but a proxy-related filing.
2015-04-22 English
DEFINITIVE PROXY STATEMENT
Proxy Solicitation & Information Statement
2015-04-22 English
AMENDMENT NO. 1 TO FORM S-1
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 1 to Form S-1 Registration Statement filed with the SEC. It is a registration statement under the Securities Act of 1933 for a public offering of common stock by SCYNEXIS, Inc. The text includes details about the offering, underwriting, risk factors, and company information typical of a registration statement for an initial or follow-on public offering. This is not a financial report, earnings release, or management discussion, but a capital markets filing related to fundraising and securities registration. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual filing, not just an announcement or certification.
2015-04-20 English
Regulatory Filings 2015
Regulatory Filings
2015-04-16 English
FORM S-1
Regulatory Filings Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, as indicated by multiple references to 'Form S-1', 'Registration Statement', and the Securities Act of 1933. It includes detailed information about the company, the securities being registered, underwriting, risk factors, and other disclosures typical of an initial public offering (IPO) registration statement. This type of filing is not an annual report, earnings release, or any other report type listed in the classification scheme. It is a regulatory filing specific to securities registration and offering. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous filings that do not fit other categories.
2015-04-09 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 9, 2015, by SCYNEXIS, Inc. It provides an update on the potential divestiture of a business segment and includes unaudited pro forma financial information as an exhibit. The document is relatively short (3428 characters) and serves as a current report to disclose a specific event rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Annual Report (10-K) or Interim Report (IR). Instead, it is an event-driven update, which fits the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2015-04-09 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.